Zhengye Biotechnology Holding (ZYBT) Cash & Equivalents Growth (3y) (2025)
Powered by 
Analysis
Zhengye Biotechnology Holding (ZYBT) Cash & Equivalents Growth (3y) (2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.46 Bn | 40.26 Bn | 779.09 Mn | 14.02% |
| 2 | Zoetis | 30.65 Bn | 28.98 Bn | 1.05 Bn | -4.92% |
| 3 | Elanco Animal Health | 11.82 Bn | 11.29 Bn | 798.00 Mn | 13.03% |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn | 14.16% |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | 82.64% |
| 6 | Zhengye Biotechnology Holding | 75.29 Mn | 68.19 Mn | - | 73.01% |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 777.88% |